lipid nanoparticle (LNP)
A lipid nanoparticle, almost always shortened to LNP, is the carrier that made mRNA vaccines possible. Naked nucleic acids like mRNA are large, fragile and negatively charged, so they cannot cross cell membranes on their own and are quickly chewed up by enzymes. An LNP is a tiny ball of lipids that wraps the nucleic acid up, hides its charge, protects it, and helps smuggle it into cells.
The clever ingredient is the ionizable lipid. At the acidic conditions used during manufacture it carries a positive charge that grips the negatively charged nucleic acid, but at the neutral pH of blood it becomes nearly uncharged, which keeps the particle relatively non-toxic and stealthy. Once the LNP is taken into a cell and trapped in an acidic compartment, the lipid charges up again and helps break out, releasing its cargo inside. A typical LNP also contains a helper phospholipid, cholesterol, and a polyethylene glycol lipid that controls size and stability.
LNPs are a major success but come with real constraints. They are sensitive to temperature, which is why some mRNA vaccines need deep-cold storage; they tend to home to the liver unless deliberately redirected; and the ionizable lipids and PEG components can occasionally provoke immune or allergic reactions. They are not the same as a hollow liposome, even though both are made of lipids.
The COVID-19 mRNA vaccines deliver their mRNA inside lipid nanoparticles; without the LNP the mRNA would be destroyed before it ever reached a cell to make the vaccine protein.
LNPs turned a fragile genetic molecule into a usable, large-scale medicine.